CENTRAL BANK & TRUST CO - BAXTER INTL INC ownership

BAXTER INTL INC's ticker is BAX and the CUSIP is 071813109. A total of 885 filers reported holding BAXTER INTL INC in Q3 2023. The put-call ratio across all filers is 0.40 and the average weighting 0.2%.

About BAXTER INTL INC

Baxter International Inc. is a global healthcare company that specializes in developing and manufacturing medical products and therapies. The company has a long history of innovation and has been at the forefront of developing life-saving treatments for patients around the world.

Baxter's product portfolio includes a wide range of medical devices, pharmaceuticals, and biotechnology products. The company's products are used in hospitals, clinics, and other healthcare settings to treat a variety of conditions, including hemophilia, immune disorders, kidney disease, and other chronic and acute medical conditions.

Baxter's commitment to innovation has helped the company maintain a strong position in the healthcare industry. The company invests heavily in research and development, and has a strong pipeline of new products in development.

Baxter's leadership team is also a key strength of the company. The CEO, José Almeida, has a strong track record of success in the healthcare industry, and has been instrumental in driving the company's growth and success.

Overall, Baxter International Inc. is a strong and innovative company that is well-positioned to continue delivering value to patients, healthcare providers, and investors alike. With a strong product portfolio, a commitment to innovation, and a talented leadership team, Baxter is a company that investors should keep an eye on in the years to come.

It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.

Quarter-by-quarter ownership
CENTRAL BANK & TRUST CO ownership history of BAXTER INTL INC
ValueSharesWeighting
Q3 2023$3,546
-17.2%
940.0%0.00%0.0%
Q2 2023$4,282
-12.0%
94
-21.7%
0.00%0.0%
Q1 2023$4,866
+1.6%
120
+27.7%
0.00%0.0%
Q4 2022$4,791
-4.2%
940.0%0.00%0.0%
Q3 2022$5,000
-16.7%
940.0%0.00%0.0%
Q2 2022$6,000
-14.3%
940.0%0.00%0.0%
Q1 2022$7,000
-12.5%
940.0%0.00%0.0%
Q4 2021$8,0000.0%940.0%0.00%0.0%
Q3 2021$8,0000.0%940.0%0.00%0.0%
Q2 2021$8,000
-57.9%
94
-57.3%
0.00%
-66.7%
Q1 2021$19,000
+5.6%
2200.0%0.00%0.0%
Q4 2020$18,0000.0%2200.0%0.00%0.0%
Q3 2020$18,000
-5.3%
2200.0%0.00%
-25.0%
Q2 2020$19,000
-32.1%
220
-36.4%
0.00%
+33.3%
Q1 2020$28,000
+55.6%
346
+57.3%
0.00%
-25.0%
Q4 2019$18,000
-5.3%
2200.0%0.00%0.0%
Q3 2019$19,000
+90.0%
220
+74.6%
0.00%
+100.0%
Q2 2019$10,000
+25.0%
126
+26.0%
0.00%0.0%
Q1 2019$8,000
-20.0%
100
-33.3%
0.00%
-33.3%
Q4 2018$10,000
-16.7%
1500.0%0.00%0.0%
Q3 2018$12,000
+200.0%
150
+50.0%
0.00%
+200.0%
Q1 2016$4,0000.0%1000.0%0.00%0.0%
Q4 2015$4,000
+33.3%
1000.0%0.00%0.0%
Q3 2015$3,000
-78.6%
100
-50.0%
0.00%
-75.0%
Q2 2015$14,000
+100.0%
200
+100.0%
0.00%
+100.0%
Q1 2015$7,0000.0%1000.0%0.00%0.0%
Q4 2014$7,000
-98.3%
100
-98.3%
0.00%
-98.8%
Q2 2014$416,000
+99.0%
5,989
+111.0%
0.16%
+96.3%
Q1 2014$209,000
-49.8%
2,839
-52.6%
0.08%
-49.1%
Q4 2013$416,000
+5.9%
5,9890.0%0.16%
-8.5%
Q3 2013$393,000
-99.9%
5,989
-34.2%
0.18%
-41.3%
Q2 2013$631,490,0009,1020.30%
Other shareholders
BAXTER INTL INC shareholders Q3 2023
NameSharesValueWeighting ↓
JONES ROAD CAPITAL MANAGEMENT, L.P. 200,000$7,548,0006.60%
BOONE CAPITAL MANAGEMENT LLC 469,405$17,715,3455.59%
Soditic Asset Management LLP 186,920$7,054,3615.43%
JONES ROAD CAPITAL MANAGEMENT, L.P. 131,000$4,943,9404.32%
Camber Capital Management LP 3,000,000$113,2203.73%
Carmignac Gestion 4,848,773$182,991,7183.36%
SHAPIRO CAPITAL MANAGEMENT LLC 3,028,799$114,306,8743.33%
Hillman Capital Management, Inc. 219,248$8,274,4203.19%
Cincinnati Specialty Underwriters Insurance CO 201,500$7,604,6102.90%
Callodine Capital Management, LP 265,000$10,001,1002.79%
View complete list of BAXTER INTL INC shareholders